Literature DB >> 6389912

Carotid involvement in aortic dissection diagnosed by duplex scanning.

P K Zirkle, J R Wheeler, R T Gregory, S O Snyder, R G Gayle, K Sorrell.   

Abstract

Symptomatic carotid dissection following repair of a proximal aortic arch dissection has been successfully diagnosed by noninvasive ultrasonic duplex scanning. Angiographic confirmation, follow-up examinations by duplex scanner, and conservative management with heparin anticoagulation and tight blood pressure control are discussed. The differing etiologies and potential neurologic complications following aortic root dissection vs. spontaneous cervical carotid dissection are considered with a review of the current literature. Although diagnosis can be achieved through arteriography, the combined modalities of duplex scanning allow evaluation of both anatomic and hemodynamic factors. Conservative therapy may prove the most appropriate mode of management in these neurologically unstable patients.

Entities:  

Mesh:

Year:  1984        PMID: 6389912

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  3 in total

1.  Doppler color flow imaging of common carotid artery dissection.

Authors:  W Steinke; A Schwartz; M Hennerici
Journal:  Neuroradiology       Date:  1990       Impact factor: 2.804

2.  Colour-coded Doppler sonography of common carotid artery dissection.

Authors:  S Trattnig; T Rand; M Thurnher; M Breitenseher; K Daha
Journal:  Neuroradiology       Date:  1995-02       Impact factor: 2.804

3.  Guidelines for Intravenous Thrombolysis (Recombinant Tissue-type Plasminogen Activator), the Third Edition, March 2019: A Guideline from the Japan Stroke Society.

Authors:  Kazunori Toyoda; Masatoshi Koga; Yasuyuki Iguchi; Ryo Itabashi; Manabu Inoue; Yasushi Okada; Kuniaki Ogasawara; Akira Tsujino; Yasuhiro Hasegawa; Taketo Hatano; Hiroshi Yamagami; Toru Iwama; Yoshiaki Shiokawa; Yasuo Terayama; Kazuo Minematsu
Journal:  Neurol Med Chir (Tokyo)       Date:  2019-12-05       Impact factor: 1.742

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.